Source: MEMPHIS BUSINESS JOURNAL

US BIOLOGIC: U.S. Biologic moving forward with Lyme disease prevention product

Memphis-based U.S. Biologic is looking to rabies prevention as inspiration for the launch of its first product. The company, which has developed an oral bait Lyme disease vaccine that is distributed to white-footed mice in fields around the northeast, is taking a similar approach as rabies prevention with the delivery method for its product. According to Mason Kauffman, the company’s president and CEO, a similar method of leaving bait with the vaccine inside in wooded areas for wolves and raccoons…

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Mason Kauffman's photo - Chairman & CEO of US BIOLOGIC

Chairman & CEO

Mason Kauffman

CEO Approval Rating

56/100

Read more